Kefu Yu

1.1k total citations
40 papers, 830 citations indexed

About

Kefu Yu is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Kefu Yu has authored 40 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Kefu Yu's work include Glioma Diagnosis and Treatment (9 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Kefu Yu is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Kefu Yu collaborates with scholars based in China, United States and Pakistan. Kefu Yu's co-authors include Sheldon S. Miller, Ward Peterson, Song Lin, Xiaohui Ren, Haihui Jiang, Zhigang Zhao, Qiang Zhang, Bingxiang Zhao, Mingxiao Li and Xuan Zhang and has published in prestigious journals such as Journal of Neuroscience, Environmental Science & Technology and Biomaterials.

In The Last Decade

Kefu Yu

40 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kefu Yu China 16 317 132 128 103 102 40 830
Maria Caffo Italy 21 309 1.0× 301 2.3× 84 0.7× 135 1.3× 77 0.8× 98 1.3k
Stefano Martellucci Italy 19 454 1.4× 210 1.6× 40 0.3× 52 0.5× 136 1.3× 45 898
Bernhard Erdlenbruch Germany 18 448 1.4× 210 1.6× 79 0.6× 46 0.4× 175 1.7× 32 965
Linhao You China 16 313 1.0× 114 0.9× 102 0.8× 127 1.2× 47 0.5× 20 930
Sara A. Litwak Australia 14 311 1.0× 144 1.1× 66 0.5× 55 0.5× 75 0.7× 21 828
Claudia Nesti Italy 25 995 3.1× 123 0.9× 43 0.3× 100 1.0× 107 1.0× 82 1.9k
Diane Bouïs United States 11 357 1.1× 35 0.3× 96 0.8× 105 1.0× 92 0.9× 15 909
Qingchun Mu China 19 551 1.7× 124 0.9× 90 0.7× 220 2.1× 96 0.9× 48 1.1k
Yuemin Ding China 13 355 1.1× 37 0.3× 29 0.2× 63 0.6× 96 0.9× 29 722
Lin Zhong China 22 578 1.8× 46 0.3× 134 1.0× 162 1.6× 181 1.8× 72 1.5k

Countries citing papers authored by Kefu Yu

Since Specialization
Citations

This map shows the geographic impact of Kefu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefu Yu more than expected).

Fields of papers citing papers by Kefu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kefu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefu Yu. The network helps show where Kefu Yu may publish in the future.

Co-authorship network of co-authors of Kefu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Kefu Yu. A scholar is included among the top collaborators of Kefu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefu Yu. Kefu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Yong, Kefu Yu, Weicheng Shen, et al.. (2024). Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity. Neuro-Oncology. 27(1). 140–154. 11 indexed citations
2.
3.
Yu, Kefu, et al.. (2024). Knowledge structure and global trends of machine learning in stroke over the past decade: A scientometric analysis. Heliyon. 10(2). e24230–e24230. 4 indexed citations
4.
Zheng, Yu, Haihui Jiang, Daosheng Huang, et al.. (2023). Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment. Cellular and Molecular Immunology. 21(1). 47–59. 21 indexed citations
5.
Xu, Yanan, Haijing Guan, Kefu Yu, Nan Ji, & Zhigang Zhao. (2023). Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis. Frontiers in Pharmacology. 14. 1191480–1191480. 4 indexed citations
6.
Yu, Kefu, et al.. (2023). Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis. Human Vaccines & Immunotherapeutics. 19(1). 2207441–2207441. 13 indexed citations
7.
Cui, Yong, Xiaohui Ren, Ming Li, et al.. (2022). Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series. Frontiers in Oncology. 12. 901797–901797. 25 indexed citations
8.
Li, Mingxiao, Xiaohui Ren, Jincheng Wang, et al.. (2021). Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features. Frontiers in Oncology. 11. 627325–627325. 12 indexed citations
9.
Li, Mingxiao, Weiwei Zhang, Xiaohui Ren, et al.. (2021). Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma. Cancer Science. 112(9). 3699–3710. 18 indexed citations
10.
Jiang, Haihui, Kefu Yu, Mingxiao Li, et al.. (2020). Classification of Progression Patterns in Glioblastoma: Analysis of Predictive Factors and Clinical Implications. Frontiers in Oncology. 10. 590648–590648. 49 indexed citations
11.
Li, Mingxiao, Xiaohui Ren, Haihui Jiang, et al.. (2019). Supratentorial high-grade astrocytoma with leptomeningeal spread to the fourth ventricle: a lethal dissemination with dismal prognosis. Journal of Neuro-Oncology. 142(2). 253–261. 13 indexed citations
12.
Mei, Shenghui, Chun Zeng, Xiaohui Ren, et al.. (2018). Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC–MS/MS in patients receiving high-dose methotrexate therapy. Journal of Pharmaceutical and Biomedical Analysis. 158. 300–306. 16 indexed citations
13.
Yu, Kefu, Ting Zhong, Limin Luo, et al.. (2015). Does ligand–receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL?. Journal of drug targeting. 23(10). 897–909. 8 indexed citations
14.
Luo, Limin, Yue Huang, Bingxiang Zhao, et al.. (2012). Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel. Biomaterials. 34(4). 1102–1114. 87 indexed citations
15.
Zhao, Bingxiang, Yang Zhao, Yue Huang, et al.. (2011). The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Biomaterials. 33(8). 2508–2520. 89 indexed citations
16.
Clewell, Rebecca A., et al.. (2003). Predicting Neonatal Perchlorate Dose and Inhibition of Iodide Uptake in the Rat during Lactation Using Physiologically-Based Pharmacokinetic Modeling. Toxicological Sciences. 74(2). 416–436. 56 indexed citations
17.
Yu, Kefu. (2000). In Vivo Kinetics of Trichloroacetate in Male Fischer 344 Rats. Toxicological Sciences. 54(2). 302–311. 8 indexed citations
18.
Yu, Kefu, Qin Chen, Hong Liu, Yi Zhan, & James Stevens. (1994). Signalling the molecular stress response to nephrotoxic and mutagenic cysteine conjugates: Differential roles for protein synthesis and calcium in the induction of c‐fos and c‐myc mRNA in LLC‐PK1 cells. Journal of Cellular Physiology. 161(2). 303–311. 12 indexed citations
19.
SERVE, M. P., et al.. (1990). Metabolism and nephrotoxicity of Indan in male fischer 344 rats. Journal of Toxicology and Environmental Health. 29(4). 409–416. 2 indexed citations
20.
Henningsen, Gerry M., et al.. (1987). The metabolism of t-butylcyclohexane in fischer-344 male rats with hyaline droplet nephropathy. Toxicology Letters. 39(2-3). 313–318. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Caffo Breakdown of academic impact, for papers by Stefano Martellucci Breakdown of academic impact, for papers by Bernhard Erdlenbruch Breakdown of academic impact, for papers by Linhao You Breakdown of academic impact, for papers by Sara A. Litwak Breakdown of academic impact, for papers by Claudia Nesti Breakdown of academic impact, for papers by Diane Bouïs Breakdown of academic impact, for papers by Qingchun Mu Breakdown of academic impact, for papers by Yuemin Ding Breakdown of academic impact, for papers by Lin Zhong
Rankless by CCL
2026